keldy2114
2021-10-26
55555555
Ocugen soared over 20% in morning trading because of WHO’s meeting on its partner’s COVID-19 shot
免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
我们需要你的真知灼见来填补这片空白
打开APP，发表看法
APP内打开
发表看法
3
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":852834589,"tweetId":"852834589","gmtCreate":1635256741477,"gmtModify":1635257085346,"author":{"id":3578437900701319,"idStr":"3578437900701319","authorId":3578437900701319,"authorIdStr":"3578437900701319","name":"keldy2114","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":21,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>55555555</p></body></html>","htmlText":"<html><head></head><body><p>55555555</p></body></html>","text":"55555555","highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/852834589","repostId":1110933668,"repostType":4,"repost":{"id":"1110933668","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1635255312,"share":"https://www.laohu8.com/m/news/1110933668?lang=&edition=full","pubTime":"2021-10-26 21:35","market":"us","language":"en","title":"Ocugen soared over 20% in morning trading because of WHO’s meeting on its partner’s COVID-19 shot","url":"https://stock-news.laohu8.com/highlight/detail?id=1110933668","media":"Tiger Newspress","summary":"Ocugen soared over 20% in morning trading because of WHO’s meeting on its partner’s COVID-19 shot.WH","content":"<p>Ocugen soared over 20% in morning trading because of WHO’s meeting on its partner’s COVID-19 shot.<img src=\"https://static.tigerbbs.com/451373be40f4fe6f0e08dacaa59f21b8\" tg-width=\"765\" tg-height=\"558\" width=\"100%\" height=\"auto\">WHO will make a decision on the vaccine developed by Bharat Biotech based on the recommendations of the Technical Advisory Group today.</p>\n<p>“WHO has been working closely with Bharat Biotech to complete the dossier. The technical advisory group will meet on Oct 26th to consider EUL for Covaxin,”WHO Chief Scientist Soumya Swaminathan said on Twitter recently.</p>\n<p>Ocugen cooperated with Bharat Biotech for the commercialization of Covaxin in the United States and Canada.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Ocugen soared over 20% in morning trading because of WHO’s meeting on its partner’s COVID-19 shot</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOcugen soared over 20% in morning trading because of WHO’s meeting on its partner’s COVID-19 shot\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-10-26 21:35</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Ocugen soared over 20% in morning trading because of WHO’s meeting on its partner’s COVID-19 shot.<img src=\"https://static.tigerbbs.com/451373be40f4fe6f0e08dacaa59f21b8\" tg-width=\"765\" tg-height=\"558\" width=\"100%\" height=\"auto\">WHO will make a decision on the vaccine developed by Bharat Biotech based on the recommendations of the Technical Advisory Group today.</p>\n<p>“WHO has been working closely with Bharat Biotech to complete the dossier. The technical advisory group will meet on Oct 26th to consider EUL for Covaxin,”WHO Chief Scientist Soumya Swaminathan said on Twitter recently.</p>\n<p>Ocugen cooperated with Bharat Biotech for the commercialization of Covaxin in the United States and Canada.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"OCGN":"Ocugen"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1110933668","content_text":"Ocugen soared over 20% in morning trading because of WHO’s meeting on its partner’s COVID-19 shot.WHO will make a decision on the vaccine developed by Bharat Biotech based on the recommendations of the Technical Advisory Group today.\n“WHO has been working closely with Bharat Biotech to complete the dossier. The technical advisory group will meet on Oct 26th to consider EUL for Covaxin,”WHO Chief Scientist Soumya Swaminathan said on Twitter recently.\nOcugen cooperated with Bharat Biotech for the commercialization of Covaxin in the United States and Canada.","news_type":1},"isVote":1,"tweetType":1,"viewCount":234,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":8,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/852834589"}
精彩评论